Fortress Biotech, Inc. Accounts Payable
Fortress Biotech, Inc. (FBIO) had Accounts Payable of $11.86 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $11.86M.
- 2026-03-31: Accounts Payable, Current $14.14M.
- 2025-12-31: Accounts Payable, Current $14.24M.
- 2025-09-30: Accounts Payable, Current $18.77M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $11.86M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $14.14M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $14.24M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $18.77M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $20.19M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $27.82M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $31.64M 10-K · filed 2026-03-31 |
| 2024-09-30 | $34.03M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $37.96M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $41.80M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $34.81M 10-K · filed 2025-03-31 |
| 2023-09-30 | $44.73M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $48.59M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $65.87M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $57.24M 10-K · filed 2024-03-28 |
| 2022-09-30 | $55.77M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $53.94M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $44.53M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $47.43M 10-K · filed 2023-03-31 |
| 2021-09-30 | $42.71M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $14.27M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $11.41M 10-K · filed 2022-03-28 |
| 2016-06-30 | $5.13M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $2.35M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.87M 10-Q · filed 2016-08-09 |
| 2015-09-30 | $1.29M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $583.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $664.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $366.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $333.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $331.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $872.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $468.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $1.11M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $1.43M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $676.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $1.03M 10-K · filed 2014-03-14 |
| 2012-09-30 | $840.00K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $753.00K 10-Q · filed 2012-08-08 |
| 2012-03-31 | $1.00M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $575.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $902.00K 10-Q · filed 2011-11-14 |
| 2010-12-31 | $476.00K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |